{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:28:06Z","timestamp":1793302086497,"version":"4.5.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Tuberc."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Pulmonary tuberculosis (TB), caused by\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      , is the leading infectious disease globally. The lengthy treatment regimen and the potential side effects increase the probability of relapse and of developing drug resistance. These factors highlight the need for new therapeutic strategies, including host-directed therapies and anti-virulence approaches. However, the drug discovery pipeline is often limited by the simplicity of\n                      <jats:italic>in vitro<\/jats:italic>\n                      models and the cost and scalability challenges of mammalian\n                      <jats:italic>in vivo<\/jats:italic>\n                      models. In this study, we developed a cost-effective administration method using the\n                      <jats:italic>Drosophila melanogaster<\/jats:italic>\n                      \u2013\n                      <jats:italic>Mycobacterium marinum<\/jats:italic>\n                      infection model called \u201cyeast-drop\u201d. This approach facilitates oral delivery and reduces the quantity of compound currently needed for treatment in the fly model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We compared the yeast-drop methodology with the standard method commonly used in\n                      <jats:italic>Drosophila<\/jats:italic>\n                      studies. Additionally, we assessed the efficacy of benchmarking antibiotics, host-directed therapies (HDTs), and anti-virulence compounds for TB treatment by measuring fly survival and bacterial burden.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Flies treated with the \u201cyeast-drop\u201d method showed a significant improvement in survival probability and a reduction in colony-forming units (CFUs) compared to non-treated flies. This was comparable to the results achieved with the standard feeding method. Among the compounds tested, linezolid proved to be the most effective antibiotic. HDTs such as aspirin, metformin, and simvastatin also enhanced survival rates and reduced CFUs following treatment, demonstrating conserved immune and metabolic mechanisms between flies and mammals. Similarly, BBH7 and ethoxzolamide, which act as anti-virulence agents, further reinforce the translational value of this type of treatment in the\n                      <jats:italic>Drosophila<\/jats:italic>\n                      model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Overall, the\n                      <jats:italic>Drosophila<\/jats:italic>\n                      \u2013\n                      <jats:italic>M. marinum<\/jats:italic>\n                      model, combined with the yeast-drop methodology, offers a reliable, low-cost, and biologically relevant platform for early-stage screening of antimycobacterial, host-directed, and anti-virulence compounds, effectively bridging the gap between\n                      <jats:italic>in vitro<\/jats:italic>\n                      systems and mammalian models.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/ftubr.2026.1746664","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:39:08Z","timestamp":1769495948000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The \u201cyeast-drop\u201d treatment protocol in the Drosophila model for rapid and cost-effective TB drug testing"],"prefix":"10.3389","volume":"4","author":[{"given":"Maria","family":"Vidal","sequence":"first","affiliation":[{"name":"Tuberculosis Research Unit, Germans Trias i Pujol Research Institute (IGTP)","place":["Badalona, Catalonia, Spain"]},{"name":"Department of Genetics and Microbiology, Universitat Aut\u00f2noma de Barcelona","place":["Bellaterra, Catalonia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Fuentes","sequence":"additional","affiliation":[{"name":"Tuberculosis Research Unit, Germans Trias i Pujol Research Institute (IGTP)","place":["Badalona, Catalonia, Spain"]},{"name":"Comparative Medicine and Bioimage Centre of Catalonia (CMCiB), Germans Trias i Pujol Research Institute (IGTP)","place":["Badalona, Catalonia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Escobar","sequence":"additional","affiliation":[{"name":"Department of Genetics and Microbiology, Universitat Aut\u00f2noma de Barcelona","place":["Bellaterra, Catalonia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Arch","sequence":"additional","affiliation":[{"name":"Tuberculosis Research Unit, Germans Trias i Pujol Research Institute (IGTP)","place":["Badalona, Catalonia, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere-Joan","family":"Cardona","sequence":"additional","affiliation":[{"name":"Tuberculosis Research Unit, Germans Trias i Pujol Research Institute (IGTP)","place":["Badalona, Catalonia, Spain"]},{"name":"Department of Genetics and Microbiology, Universitat Aut\u00f2noma de Barcelona","place":["Bellaterra, Catalonia, Spain"]},{"name":"Comparative Medicine and Bioimage Centre of Catalonia (CMCiB), Germans Trias i Pujol Research Institute (IGTP)","place":["Badalona, Catalonia, Spain"]},{"name":"Laboratori Cl\u00ednic Metropolitana Nord, Microbiology Department, Germans Trias i Pujol University Hospital (HUGTP)","place":["Badalona, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"B1","article-title":"Global Tuberculosis Report 2024","year":"2024"},{"key":"B2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1183\/2312508X.10021417","article-title":"\u201cTreatment of drug-susceptible and drug-resistant tuberculosis. Tuberculosis\u201d","author":"Caminero","year":"2018","journal-title":"Tuberculosis (ERS Monograph)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.2147\/IDR.S554556","article-title":"What are the real-life dilemmas and facilitators of medication adherence of patients with drug-resistant tuberculosis: a qualitative exploration of patient perspectives","volume":"18","author":"Xia","year":"2025","journal-title":"Infect Drug Resist"},{"key":"B4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s40001-025-02443-4","article-title":"Host-directed therapy for tuberculosis","volume":"30","author":"Tian","year":"2025","journal-title":"Eur J of Med Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"107130","DOI":"10.1016\/j.ijid.2024.107130","article-title":"Host-directed therapies: old and new approaches for the treatment of infections","volume":"146","author":"Goletti","year":"2024","journal-title":"Int J Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"970408","DOI":"10.3389\/fmed.2022.970408","article-title":"Host-directed therapies in pulmonary tuberculosis: updates on anti-inflammatory drugs","volume":"9","author":"Cubillos-Angulo","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7489","DOI":"10.1021\/acs.jmedchem.2c00227","article-title":"Tuberculosis drug discovery: challenges and new horizons","volume":"65","author":"Fernandes","year":"2022","journal-title":"J Med Chem"},{"key":"B8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tips.2021.11.016","article-title":"Host-directed therapies for tuberculosis: quantitative systems pharmacology approaches","volume":"43","author":"Mehta","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"104501","DOI":"10.1016\/j.drudis.2025.104501","article-title":"Targeting virulence in Mycobacterium tuberculosis and nontuberculous mycobacteria: focus on anti-infective drug design","volume":"30","author":"Chiarelli","year":"2025","journal-title":"Drug Discov Today"},{"key":"B10","doi-asserted-by":"publisher","first-page":"104429","DOI":"10.1016\/j.ebiom.2022.104429","article-title":"Pathogen-associated gene discovery workflows for novel antivirulence therapeutic development","volume":"88","author":"Lau","year":"2023","journal-title":"EBioMedicine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"7485","DOI":"10.3390\/ijms26157485","article-title":"Drosophila melanogaster: how and why it became a model organism","volume":"26","author":"Giansanti","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B12","first-page":"1478263","article-title":"Drosophila melanogaster experimental model to test new antimicrobials : a methodological approach","volume-title":"Front Microbiol","author":"Vidal","year":"2024"},{"key":"B13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/jac\/dks425","article-title":"Mycobacterium marinum infection in Drosophila melanogaster for antimycobacterial activity assessment","volume":"68","author":"Oh","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1093\/jac\/dku024","article-title":"Novel drug combination for Mycobacterium abscessus disease therapy identified in a Drosophila infection model","volume":"69","author":"Oh","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1038\/s41598-017-03477-3","article-title":"Ohmyungsamycins promote antimicrobial responses through autophagy activation via AMP-activated protein kinase pathway","volume":"7","author":"Kim","year":"2017","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.1038\/s41598-019-43201-x","article-title":"Combination of repurposed drug diosmin with amoxicillin-clavulanic acid causes synergistic inhibition of mycobacterial growth","volume":"9","author":"Pushkaran","year":"2019","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"113740","DOI":"10.1016\/j.ab.2020.113740","article-title":"A standardized method for incorporation of drugs into food for use with Drosophila melanogaster","volume":"599","author":"Kruger","year":"2020","journal-title":"Anal Biochem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40635-016-0075-4","article-title":"Cost of surviving sepsis: a novel model of recovery from sepsis in Drosophila melanogaster","volume":"4","author":"Kaynar","year":"2016","journal-title":"Intensive Care Med Exp"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e75332","DOI":"10.1371\/journal.pone.0075332","article-title":"Quantifying variation in the ability of yeasts to attract Drosophila melanogaster","volume":"8","author":"Palanca","year":"2013","journal-title":"PLoS ONE"},{"key":"B20","doi-asserted-by":"publisher","first-page":"8075","DOI":"10.1002\/ece3.5366","article-title":"Are Drosophila preferences for yeasts stable or contextual?","volume":"9","author":"G\u00fcnther","year":"2019","journal-title":"Ecol Evol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1128\/IAI.72.11.6306-6312.2004","article-title":"Mycobacterium marinum strains can be divided into two distinct types based on genetic diversity and virulence","volume":"72","author":"van der Sar","year":"2004","journal-title":"Infect Immun"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1128\/IAI.71.6.3540-3550.2003","volume":"71","author":"Dionne","year":"2003","journal-title":"Drosophila melanogaster"},{"key":"B23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fcimb.2020.00214","article-title":"Drosophila as a model organism in host\u2013pathogen interaction studies","volume":"10","author":"Younes","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1072715","DOI":"10.3389\/fphar.2022.1072715","article-title":"Using Drosophila melanogaster as a suitable platform for drug discovery from natural products in inflammatory bowel disease","volume":"13","author":"Xiu","year":"2022","journal-title":"Front Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1124\/pr.110.003293","article-title":"Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery","volume":"63","author":"Pandey","year":"2011","journal-title":"Pharmacol Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/emph\/eoad029","article-title":"The reproductive status determines tolerance and resistance to Mycobacterium marinum in Drosophila melanogaster","volume":"11","author":"Arch","year":"2023","journal-title":"Evol Med Public Health"},{"key":"B27","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1128\/microbiolspec.TNMI7-0038-2016","volume":"5","author":"Aubry","year":"2017","journal-title":"Mycobacterium marinum. Microbiol Spectr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"999762","DOI":"10.3389\/fevo.2022.999762","article-title":"Diverging olfactory sensitivities to yeast volatiles reflect resource partitioning of tephritids and drosophilids","volume":"10","author":"Biasazin","year":"2022","journal-title":"Front Ecol Evol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"iyae048","DOI":"10.1093\/genetics\/iyae048","article-title":"Quantitative genetic analysis of attractiveness of yeast products to Drosophila","volume":"227","author":"Yan","year":"2024","journal-title":"Genetics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2084906","DOI":"10.1155\/2022\/2084906","article-title":"Preparation and photocatalytic characterization of modified nano TiO2\/Nd\/rice husk ash material for rifampicin removal in aqueous solution","volume":"2022","author":"Dang Thi Ngoc","year":"2022","journal-title":"J Anal Methods Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"113941","DOI":"10.1016\/j.jpba.2021.113941","article-title":"Evaluation of the effect of temperature on the stability and antimicrobial activity of rifampicin quinone","volume":"197","author":"Sutradhar","year":"2021","journal-title":"J Pharm Biomed Anal"},{"key":"B32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1310\/hpj4902-136","volume":"49","year":"2014","journal-title":"Light-sensitive injectable prescription drugs. Hosp Pharm"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1323333","DOI":"10.3389\/fimmu.2024.1323333","article-title":"Potent induction of trained immunity by Saccharomyces cerevisiae \u03b2-glucans","volume":"15","author":"Vuscan","year":"2024","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1474516","DOI":"10.3389\/fimmu.2024.1474516","article-title":"Candida albicans infection model in Drosophila melanogaster suggests a strain-specific virulent factor boosting a stormy innate immune response","volume":"15","author":"Cortacans","year":"2024","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0138129","DOI":"10.1371\/journal.pone.0138129","article-title":"Quantitative genetics of food intake in Drosophila melanogaster","volume":"10","author":"Garlapow","year":"2015","journal-title":"PLoS ONE"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1101\/2025.05.22.655590","article-title":"Sex differences in Drosophila intestinal metabolism contribute to sexually dimorphic infection outcome and alter gut pathogen virulence","author":"Rubinic","year":"2025","journal-title":"bioRxiv."},{"key":"B37","doi-asserted-by":"publisher","first-page":"240265","DOI":"10.1098\/rsob.240265","article-title":"Evolution of resistance and disease tolerance mechanisms to oral bacterial infection in Drosophila melanogaster","volume":"15","author":"Paulo","year":"2025","journal-title":"Open Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.2147\/DDDT.S136335","article-title":"Evaluation of the stability of linezolid in aqueous solution and commonly used intravenous fluids","volume":"11","author":"Taylor","year":"2017","journal-title":"Drug Des Dev Ther"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3389\/fphar.2019.01389","article-title":"Linezolid and its immunomodulatory effect: in vitro and in vivo evidence","volume":"10","author":"Wang","year":"2019","journal-title":"Front Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.micpath.2012.11.012","article-title":"Drosophila melanogaster as a model to explore the effects of methicillin-resistant Staphylococcus aureus strain type on virulence and response to linezolid treatment","volume":"55","author":"Ben-Ami","year":"2013","journal-title":"Microb Pathog"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1183\/09031936.00022912","article-title":"Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis","volume":"40","author":"Sotgiu","year":"2012","journal-title":"Eur Respir J"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1128\/AAC.44.11.3133-3136.2000","article-title":"Antibiotic susceptibility pattern of Mycobacterium marinum","volume":"44","author":"Aubry","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0036022","DOI":"10.1128\/iai.00360-22","article-title":"Impact of chronic infection on resistance and tolerance to secondary infection in Drosophila melanogaster","volume":"91","author":"Wukitch","year":"2023","journal-title":"Infect Immun"},{"key":"B44","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3389\/fimmu.2018.00798","article-title":"A beneficial effect of low-dose aspirin in a murine model of active tuberculosis","volume":"9","author":"Kroesen","year":"2018","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/jcm8070923","article-title":"Use of antiplatelet agents and survival of tuberculosis patients: a population-based Cohort study","volume":"8","author":"Lee","year":"2019","journal-title":"J Clin Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.3390\/molecules28145300","article-title":"Dietary supplementation of aspirin promotes Drosophila defense against viral infection","volume":"28","author":"Kong","year":"2023","journal-title":"Molecules"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e67358","DOI":"10.7554\/eLife.67358","article-title":"Drosophila STING protein has a role in lipid metabolism","volume":"10","author":"Akhmetova","year":"2021","journal-title":"eLife"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1004860","DOI":"10.1371\/journal.pgen.1004860","article-title":"Enhanced longevity by ibuprofen, conserved in multiple species, occurs in yeast through inhibition of tryptophan import","volume":"10","author":"He","year":"2014","journal-title":"PLoS Genet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/infdis\/jit152","article-title":"Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis","volume":"208","author":"Vilaplana","year":"2013","journal-title":"J Infect Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"19428","DOI":"10.18632\/oncotarget.5118","article-title":"Influence of non-steroidal anti-inflammatory drugs on Drosophila melanogaster longevity","volume":"6","author":"Danilov","year":"2015","journal-title":"Oncotarget"},{"key":"B51","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/978-3-319-43589-3_16","article-title":"The role of AMPK in Drosophila melanogaster","volume":"107","author":"Sinnett","year":"2016","journal-title":"Exp Suppl"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1038\/s44318-024-00155-9","article-title":"Reactive oxygen species activate the Drosophila TNF receptor Wengen for damage-induced regeneration","volume":"43","author":"Esteban-Collado","year":"2024","journal-title":"EMBO J"},{"key":"B53","first-page":"682","article-title":"Drosophila as a robust model system for assessing autophagy : a review","volume-title":"Toxics","author":"Demir","year":"2023"},{"key":"B54","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/infdis\/jit550","article-title":"Statin therapy reduces the Mycobacterium tuberculosis Burden in human macrophages and in mice by enhancing autophagy and phagosome maturation","volume":"209","author":"Parihar","year":"2014","journal-title":"J Infect Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e39581","DOI":"10.1371\/journal.pone.0039581","article-title":"Statin treatment increases lifespan and improves cardiac health in Drosophila by decreasing specific protein prenylation","volume":"7","author":"Spindler","year":"2012","journal-title":"PLoS ONE"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1101\/2024.12.27.630478","article-title":"Sexually dimorphic ATF4 expression in the fat confers female stress tolerance in Drosophila melanogaster","author":"Grmai","year":"2024","journal-title":"bioRxiv"},{"key":"B57","doi-asserted-by":"publisher","first-page":"19648","DOI":"10.1038\/s41598-025-04497-0","article-title":"Drosophila melanogaster as a model organism to investigate sex-specific differences","volume":"15","author":"D\u00e4hn","year":"2025","journal-title":"Sci Rep"},{"key":"B58","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41467-019-08405-9","article-title":"Corticosteroids inhibit mycobacterium tuberculosis-induced necrotic host cell death by abrogating mitochondrial membrane permeability transition","volume":"10","author":"Gr\u00e4b","year":"2019","journal-title":"Nat Commun"},{"key":"B59","doi-asserted-by":"publisher","first-page":"20774","DOI":"10.1073\/pnas.1009223107","article-title":"Participation of the p38 pathway in Drosophila host defense against pathogenic bacteria and fungi","volume":"107","author":"Chen","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e1004565","DOI":"10.1371\/journal.pgen.1004565","article-title":"The MAP kinase p38 is part of Drosophila melanogaster's circadian clock","volume":"10","author":"Dusik","year":"2014","journal-title":"PLoS Genet"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/sj.embor.7400282","article-title":"A Drosophila p38 orthologue is required for environmental stress responses","volume":"5","author":"Craig","year":"2004","journal-title":"EMBO Rep"},{"key":"B62","doi-asserted-by":"publisher","first-page":"11466","DOI":"10.1021\/acsomega.1c00521","article-title":"BIRB796, an inhibitor of p38 mitogen-activated protein kinase, inhibits proliferation and invasion in glioblastoma cells","volume":"6","author":"Zhao","year":"2021","journal-title":"ACS Omega"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e00766","DOI":"10.1128\/JB.00766-17","article-title":"PhoPR positively regulates whiB3 expression in response to low pH in pathogenic mycobacteria","volume":"200","author":"Feng","year":"2018","journal-title":"J Bacteriol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e00047","DOI":"10.1128\/jb.00047-25","article-title":"Mycobacterium marinum as a model for understanding principles of mycobacterial pathogenesis","volume":"207","author":"Menon","year":"2025","journal-title":"J Bacteriol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"102747","DOI":"10.1016\/j.xpro.2023.102747","article-title":"Protocol to build a drug-testing pipeline using large populations of Drosophila melanogaster","volume":"4","author":"DeLoriea","year":"2023","journal-title":"ScienceDirect"},{"key":"B66","doi-asserted-by":"publisher","first-page":"55024","DOI":"10.3791\/55024","article-title":"The CApillary FEeder assay measures food intake in Drosophila melanogaster","volume":"121","author":"Diegelmann","year":"2017","journal-title":"J Vis Exp."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1002\/rcm.5187","article-title":"Profiling and quantification of Drosophila melanogaster lipids using liquid chromatography\/mass spectrometry","volume":"25","author":"Hammad","year":"2011","journal-title":"Rapid Commun Mass Spectrom"}],"container-title":["Frontiers in Tuberculosis"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftubr.2026.1746664\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:39:11Z","timestamp":1769495951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftubr.2026.1746664\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":67,"alternative-id":["10.3389\/ftubr.2026.1746664"],"URL":"https:\/\/doi.org\/10.3389\/ftubr.2026.1746664","relation":{},"ISSN":["2813-7868"],"issn-type":[{"value":"2813-7868","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"article-number":"1746664"}}